CiteFacts · FDA Drug Shortages · FDA source
Ifosfamide Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Baxter Healthcare | IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01) | Unavailable | 08/17/2026 |
| Baxter Healthcare | IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01) | Unavailable | 08/17/2026 |
| Baxter Healthcare | Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01) | Unavailable | 08/17/2026 |
| Baxter Healthcare | Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02) | Unavailable | 08/17/2026 |
| Fresenius Kabi USA, LLC | Ifosfamide, Injection, 1 g (NDC 63323-142-10) | Unavailable | 08/04/2026 |
| Hikma Pharmaceuticals USA, Inc. | Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01) | Unavailable | 08/13/2026 |
Source facts
Grouped generic ingredient: Ifosfamide Injection · 7 package records · Latest FDA row update: 08/17/2026
Therapeutic categories: Oncology, Pediatric
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.